Sustained Remission with No Dose Escalation after Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation: 1-Year Results from PRECiSE 4

被引：0
|
作者：
Sandborn, William [1 ]
Rubin, David [2 ]
Sen, David [3 ]
Feagan, Brian [4 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[3] UCB Inc, Raleigh, NC USA
[4] Univ Western Ontario, Robarts Res Inst, London, ON, Canada
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2011年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1171
引用
收藏
页码：S439 / S439
页数：1
相关论文
共 50 条
  • [1] Long-term maintenance of remission with no dose escalation after re-induction with certolizumab pegol in patients with Crohn's disease exacerbation: 3-year results from the PRECiSE 4 study
    Sandborn, W.
    Schreiber, S.
    Hanauer, S.
    Colombel, J.
    Bloomfield, R.
    Lichtenstein, G.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S14 - S14
  • [2] Sustained Remission With No Dose Escalation After Re-Induction With Certolizumab Pegol in Patients With Crohn's Disease Exacerbation Who Were NaiVE to Anti-TNF Treatment: 5-Year Results From Precise 4
    Sandborn, William J.
    Schreiber, Stefan
    Colombel, Jean-Frederic
    Sen, David L.
    Lichtenstein, Gary R.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S65 - S66
  • [3] Sustained remission with no dose escalation after re-induction with certolizumab pegol in patients with Crohn's disease exacerbation who were naive to anti-TNF treatment: 5-year results from PRECiSE 4
    Sandborn, William J.
    Schreiber, Stefan
    Colombel, Jean-Frederic
    Sen, David
    Lichtenstein, Gary R.
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S24 - S24
  • [4] Sustained remission with no dose escalation after re-induction with certolizumab pegol in patients with Crohn's disease exacerbation who were naive to anti-TNF treatment: 4-year results from PRECiSE 4.
    Sandborn, W.
    Schreiber, S.
    Hanauer, S.
    Colombel, J.
    Bloomfield, R.
    Lichtenstein, G.
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S60 - S60
  • [5] Remission Rates in Crohn's Disease Patients Treated With a Re-Induction Regimen of Certolizumab Pegol After Experiencing Disease Exacerbation: 7 Year Results From the Precise 4 Study
    Lee, Scott D.
    Schreiber, Stefan
    Schwartz, David A.
    Burakoff, Robert
    Binion, David G.
    Kayhan, Cem
    Kosutic, Gordana
    Ambarkhane, Sumeet
    Sen, David
    Hasan, Iram
    Spearman, Marshall
    Sandborn, William
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S261 - S261
  • [6] Long-term Maintenance of Remission with No Dose Escalation Aft er Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation: 3-year Results from the PRECiSE 4 Study
    Sandborn, William
    Schreiber, Stefan
    Hanauer, Stephen
    Colombel, Jean-Frederick
    Bloomfield, Ralph
    Lichtenstein, Gary
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S448 - S448
  • [7] Long-term Maintenance of Remission with No Dose Escalation After Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation Who Were Naive to Anti-TNF Treatment: 4-Year Results from the PRECiSE 4 Study
    Sandborn, William
    Schreiber, Stefan
    Hanauer, Stephen
    Colombel, Jean-Frederic
    Bloomfield, Ralph
    Lichtenstein, Gary
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S418 - S418
  • [8] Incidence and Predictors of Clinical Response, Re-induction Dose, and Maintenance Dose Escalation with Certolizumab Pegol in Crohn's Disease
    Stein, Adam C.
    Rubin, David T.
    Hanauer, Stephen B.
    Cohen, Russell D.
    [J]. INFLAMMATORY BOWEL DISEASES, 2014, 20 (10) : 1722 - 1728
  • [9] Re-induction with certolizumab pegol following disease exacerbation during maintenance therapy is effective to regain response and remission
    Lichtenstein, Gary R.
    Mitchev, Krassimir
    D'Haens, Geert
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A488 - A488
  • [10] Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study
    Lee, Scott D.
    Rubin, David T.
    Sandborn, William J.
    Randall, Charles
    Younes, Ziad
    Schreiber, Stefan
    Schwartz, David A.
    Burakoff, Robert
    Binion, David
    Dassopoulos, Themos
    Arsenescu, Razvan
    Gutierrez, Alexandra
    Scherl, Ellen
    Kayhan, Cem
    Hasan, Iram
    Kosutic, Gordana
    Spearman, Marshall
    Sen, David
    Coarse, Jason
    Hanauer, Stephen
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 (08) : 1870 - 1880
12345